Peer-reviewedLicence not statedJournal of Clinical Oncology
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial
19 affiliations
- 1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- 2Department of Radiation Oncology, Mayo Clinic, Rochester, MN
- 3Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
- 5Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
- 6Division of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ
- 7Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 8Department of General Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 9Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 10Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX
- 11Department of Breast Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- 12Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
- 13Department of Behavioral Science, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
- 14Department of Palliative, Rehabilitation, and Integrative Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 15Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- 16Department of Thoracic/Head & Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 17Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 18Department of Genitourinary Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- 19Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Related
- Metastasis-Directed Therapy Versus Systemic Therapy in Oligometastatic Endometrial Carcinoma Recurrence: A Population-Based Registry Analysis
- Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA
- Intramedullary Spinal Cord Metastasis From Oligometastatic Melanoma of Unknown Primary Treated With Stereotactic Body Radiotherapy.
- Estimating Individualized Survival Benefit of Consolidative Metastasis-Directed Radiotherapy Following Chemoimmunotherapy in Nasopharyngeal Carcinoma With Exclusive Distant Metastasis.
- Study protocol for effects of prone spinal decompression therapy in addition to Mckenzie exercises versus Mckenzie exercises only on pain and functional disability in lumbar radiculopathy-A randomized clinical trial.
BibTeX
@article{sherry2026addition,
title = {{Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial}},
author = {Alexander Dean Sherry and Cara Haymaker and Shuqi Wang and Suyu Liu and Tharakeswara Kumar Bathala and Marina Nayeli Medina-Rosales and Aaron Seo and Kieko Hara and Jay Reddy and Stephen G. Chun and Lauren Layer Mayo and Gary V. Walker and Shubham Pant and Dan Zhao and Craig A. Kovitz and David Ramirez and Chul Soo Ha and BD Smith and Daniel Gomez and Lorenzo Cohen and Albert C. Koong and Alexandre Reuben and Nizar M. Tannir and Paul Gettys Corn and Phuoc Tho Tran and Bilal Ahmed Siddiqui and Sumit Kumar Subudhi and Pavlos Msaouel and Ethan Bernard Ludmir and Chad Z. Tang},
journal = {Journal of Clinical Oncology},
year = {2026},
month = may,
doi = {10.1200/jco-25-02856},
url = {https://doi.org/10.1200/jco-25-02856},
}
RIS
TY - JOUR
TI - Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial
AU - Alexander Dean Sherry
AU - Cara Haymaker
AU - Shuqi Wang
AU - Suyu Liu
AU - Tharakeswara Kumar Bathala
AU - Marina Nayeli Medina-Rosales
AU - Aaron Seo
AU - Kieko Hara
AU - Jay Reddy
AU - Stephen G. Chun
AU - Lauren Layer Mayo
AU - Gary V. Walker
AU - Shubham Pant
AU - Dan Zhao
AU - Craig A. Kovitz
AU - David Ramirez
AU - Chul Soo Ha
AU - BD Smith
AU - Daniel Gomez
AU - Lorenzo Cohen
AU - Albert C. Koong
AU - Alexandre Reuben
AU - Nizar M. Tannir
AU - Paul Gettys Corn
AU - Phuoc Tho Tran
AU - Bilal Ahmed Siddiqui
AU - Sumit Kumar Subudhi
AU - Pavlos Msaouel
AU - Ethan Bernard Ludmir
AU - Chad Z. Tang
PY - 2026
DA - 2026/05/16
JO - Journal of Clinical Oncology
DO - 10.1200/jco-25-02856
UR - https://doi.org/10.1200/jco-25-02856
SN - 0732-183X
SN - 1527-7755
ER -